Millennium Management LLC Has $4.96 Million Position in Paragon 28, Inc. (NYSE:FNA)

Millennium Management LLC grew its holdings in Paragon 28, Inc. (NYSE:FNA - Free Report) by 5,834.0% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 725,489 shares of the company's stock after purchasing an additional 713,263 shares during the period. Millennium Management LLC owned about 0.87% of Paragon 28 worth $4,962,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Price T Rowe Associates Inc. MD boosted its holdings in shares of Paragon 28 by 16.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,622 shares of the company's stock valued at $156,000 after buying an additional 1,766 shares during the last quarter. Capstone Investment Advisors LLC lifted its stake in Paragon 28 by 9.0% in the first quarter. Capstone Investment Advisors LLC now owns 21,800 shares of the company's stock valued at $269,000 after acquiring an additional 1,800 shares during the last quarter. PNC Financial Services Group Inc. bought a new position in shares of Paragon 28 in the 4th quarter valued at about $25,000. Rhumbline Advisers increased its stake in shares of Paragon 28 by 6.0% during the 2nd quarter. Rhumbline Advisers now owns 65,727 shares of the company's stock worth $450,000 after purchasing an additional 3,720 shares during the last quarter. Finally, Nisa Investment Advisors LLC raised its holdings in shares of Paragon 28 by 46,660.0% in the 2nd quarter. Nisa Investment Advisors LLC now owns 4,676 shares of the company's stock valued at $32,000 after purchasing an additional 4,666 shares during the period. Institutional investors own 63.57% of the company's stock.

Paragon 28 Stock Performance

Paragon 28 stock traded up $0.39 during trading hours on Friday, hitting $5.72. The company had a trading volume of 826,717 shares, compared to its average volume of 597,638. Paragon 28, Inc. has a one year low of $4.84 and a one year high of $14.79. The firm has a market cap of $477.85 million, a PE ratio of -8.29 and a beta of 0.97. The firm has a 50-day moving average of $7.16 and a 200 day moving average of $7.94. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.57 and a quick ratio of 1.70.

Paragon 28 (NYSE:FNA - Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.17) earnings per share for the quarter, hitting the consensus estimate of ($0.17). Paragon 28 had a negative return on equity of 32.39% and a negative net margin of 24.64%. The business had revenue of $61.02 million during the quarter, compared to analysts' expectations of $60.08 million. During the same period last year, the firm posted ($0.13) EPS. The firm's revenue for the quarter was up 19.6% compared to the same quarter last year. On average, sell-side analysts expect that Paragon 28, Inc. will post -0.68 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. Piper Sandler reissued an "overweight" rating and set a $12.00 price target (down previously from $15.00) on shares of Paragon 28 in a research report on Friday, August 9th. Needham & Company LLC dropped their price target on Paragon 28 from $14.00 to $11.00 and set a "buy" rating on the stock in a research note on Friday, August 9th.

Paragon 28 Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.